Introducing a new test for the quantitative determination of antibodies against the SARS-CoV-2 spike protein - Roche Elecsys® Anti-SARS-CoV-2 S.

Our Genetics teams are using high-throughput sequencing to combine the testing for rare bleeding, platelet and thrombosis disorders into a single workflow.

Our Haem-Oncology team is introducing rapid genetic testing to help with the treatment management of leukaemia patients.

An increased range of tests using remote testing/self-taken small volume blood samples (home collection) and postal pathology has been developed using TDL TINIES. 

TDL Genetics offers a genetic  test to assist in the diagnosis  of primary lactose intolerance  in both children and adults.   

Bowel cancer is the fourth most common cancer in the UK but too often colorectal cancer is detected at
a late stage making it the second most common cause of cancer death in the UK